Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-14 Sale |
2024-02-16 4:15 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
10,434 | $942.28 | $9,831,727 | 33,838 (Indirect Direct) |
View |
| 2024-02-08 Sale |
2024-02-12 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
1,000 | $950 | $950,000 | 48,675 (Indirect Direct) |
View |
| 2024-02-09 Sale |
2024-02-12 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Finance & CFO |
4,919 | $953.31 | $4,689,320 | 24,431 (Indirect Direct) |
View |
| 2024-02-07 Sale |
2024-02-09 4:12 pm |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
1,000 | $950 | $950,000 | 42,265 (Indirect Direct) |
View |
| 2024-02-07 Sale |
2024-02-08 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
8,037 | $950.35 | $7,637,954 | 62,458 (Indirect Direct) |
View |
| 2024-02-05 Sale |
2024-02-06 4:08 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $934.71 | $934,710 | 13,947 (Indirect Direct) |
View |
| 2024-02-01 Sale |
2024-02-05 4:05 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $954.22 | $95,422 | 18,382 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
273 | $945.61 | $258,152 | 14,947 (Indirect Direct) |
View |
| 2024-01-30 Sale |
2024-01-31 4:52 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
827 | $959 | $793,093 | 2,209 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-25 4:18 pm |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
2,707 | $950 | $2,571,650 | 6,382 (Direct) |
View |
| 2024-01-02 Sale |
2024-01-04 4:20 pm |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO |
16,848 | $900 | $15,163,200 | 1,217,856 (Indirect Direct) |
View |
| 2024-01-02 Sale |
2024-01-04 4:17 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
274 | $873.91 | $239,451 | 15,220 (Indirect Direct) |
View |
| 2024-01-03 Sale |
2024-01-04 4:11 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
826 | $914 | $754,964 | 4,643 (Direct) |
View |
| 2024-01-02 Sale |
2024-01-04 4:11 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
1,117 | $900 | $1,005,300 | 2,989 (Direct) |
View |
| 2024-01-02 Sale |
2024-01-04 4:08 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $899.9 | $89,990 | 20,089 (Direct) |
View |
| 2023-12-27 Sale |
2023-12-29 4:06 pm |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
2,049 | $898 | $1,840,002 | 12,409 (Indirect Direct) |
View |
| 2023-12-27 Sale |
2023-12-29 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
2,448 | $856.71 | $2,097,226 | 24,431 (Indirect Direct) |
View |
| 2023-12-21 Sale |
2023-12-26 4:08 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
1,930 | $844.3 | $1,629,502 | 26,879 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-09 Exercise |
2024-02-13 4:04 pm |
N/A 2029-12-11 |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
35,375 | $0 | 56,522 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
24,941 | $951.68 | 56,522 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-13 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
12,250 | $372.46 | 56,522 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-13 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
23,125 | $381.4 | 56,522 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
1,000 | $413.33 | 48,675 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 4:02 pm |
N/A 2025-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
1,000 | $0 | 48,675 (Direct) |
View |
Ownership |
2024-02-08 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Pitofsky Jason Vice President, Controller |
0 | $0 | 15,816 (Direct) |
View |
| 2024-02-02 Tax Withholding |
2024-02-06 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
22,713 | $956.65 | 70,495 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-06 4:08 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
30,750 | $0 | 70,495 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-06 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
30,750 | $399.66 | 70,495 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-06 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
400 | $378.98 | 35,750 (Direct) |
View |
| 2024-02-02 Tax Withholding |
2024-02-06 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
281 | $956.65 | 35,750 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-06 4:08 pm |
N/A 2027-12-12 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
400 | $0 | 35,750 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
400 | $378.98 | 36,031 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 4:02 pm |
N/A 2027-12-12 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
400 | $0 | 36,031 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-02-02 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
282 | $953.42 | 36,031 (Direct) |
View |
| 2024-01-30 Exercise |
2024-01-31 4:52 pm |
N/A 2028-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
827 | $0 | 2,209 (Direct) |
View |
| 2024-01-30 Exercise |
2024-01-31 4:52 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
827 | $380.95 | 2,209 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-25 4:18 pm |
N/A 2032-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
2,707 | $0 | 6,382 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-25 4:18 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
2,707 | $625.6 | 6,382 (Direct) |
View |
| 2024-01-23 Tax Withholding |
2024-01-25 4:17 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
7,569 | $948.5 | 29,350 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-25 4:17 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
10,000 | $0 | 29,350 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-25 4:17 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
5,000 | $399.66 | 29,350 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-25 4:17 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
5,000 | $555.67 | 29,350 (Direct) |
View |
| 2024-01-23 Tax Withholding |
2024-01-25 4:17 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
776 | $948.5 | 49,400 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-25 4:17 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,600 | $378.98 | 49,400 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-25 4:17 pm |
N/A 2027-12-12 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,600 | $0 | 49,400 (Direct) |
View |
| 2024-01-24 Tax Withholding |
2024-01-25 4:17 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
352 | $951.26 | 49,400 (Direct) |
View |
| 2024-01-17 Exercise |
2024-01-18 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
500 | $378.98 | 37,441 (Direct) |
View |
| 2024-01-17 Exercise |
2024-01-18 4:02 pm |
N/A 2027-12-12 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
500 | $0 | 37,441 (Direct) |
View |
| 2024-01-17 Tax Withholding |
2024-01-18 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
354 | $932.34 | 37,441 (Direct) |
View |
| 2024-01-12 Exercise |
2024-01-17 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
800 | $378.98 | 37,795 (Direct) |
View |
| 2024-01-12 Exercise |
2024-01-17 4:03 pm |
N/A 2027-12-12 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
800 | $0 | 37,795 (Direct) |
View |
| 2024-01-12 Tax Withholding |
2024-01-17 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
568 | $928.18 | 37,795 (Direct) |
View |
| 2024-01-04 Exercise |
2024-01-08 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
500 | $378.98 | 38,363 (Direct) |
View |
| 2024-01-04 Tax Withholding |
2024-01-08 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
342 | $917.05 | 38,363 (Direct) |
View |
| 2024-01-04 Exercise |
2024-01-08 4:02 pm |
N/A 2027-12-12 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
500 | $0 | 38,363 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 4:22 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
10,000 | $0 | 36,919 (Direct) |
View |
| 2024-01-03 Tax Withholding |
2024-01-04 4:22 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
7,512 | $912.3 | 36,919 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 4:22 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
5,000 | $399.66 | 36,919 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 4:22 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
5,000 | $555.67 | 36,919 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 4:19 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
34,000 | $0 | 43,265 (Direct) |
View |
| 2024-01-03 Tax Withholding |
2024-01-04 4:19 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
24,493 | $912.3 | 43,265 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 4:19 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
34,000 | $399.66 | 43,265 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-04 4:19 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,750 | $378.98 | 55,792 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-04 4:19 pm |
N/A 2027-12-12 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,750 | $0 | 55,792 (Direct) |
View |
| 2024-01-03 Tax Withholding |
2024-01-04 4:19 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
688 | $912.3 | 55,792 (Direct) |
View |
| 2024-01-02 Tax Withholding |
2024-01-04 4:19 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
421 | $888.34 | 55,792 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:17 pm |
N/A 2034-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Schenkein David P Director |
550 | $0 | 790 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:16 pm |
N/A 2034-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Guarini Kathryn Director |
550 | $0 | 790 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:15 pm |
N/A 2034-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Thompson Craig B. Director |
1,742 | $0 | 2,061 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:11 pm |
N/A 2034-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director |
1,742 | $0 | 3,000 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 4:11 pm |
N/A 2028-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
826 | $0 | 4,643 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
826 | $380.95 | 4,643 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:11 pm |
N/A 2034-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
1,742 | $0 | 4,643 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-04 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
1,117 | $391.92 | 2,989 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-04 4:11 pm |
N/A 2026-09-09 |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
1,117 | $0 | 2,989 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:11 pm |
N/A 2034-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
1,742 | $0 | 2,989 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:10 pm |
N/A 2034-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | POON CHRISTINE A Director |
1,742 | $0 | 3,779 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:08 pm |
N/A 2034-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
1,742 | $0 | 20,089 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:07 pm |
N/A 2034-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
1,742 | $0 | 30,106 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:07 pm |
N/A 2034-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
1,742 | $0 | 7,989 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:06 pm |
N/A 2034-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1,742 | $0 | 14,151 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 4:06 pm |
N/A 2031-01-04 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
2,049 | $0 | 12,409 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 4:06 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
2,049 | $482.68 | 12,409 (Direct) |
View |
| 2023-12-27 Tax Withholding |
2023-12-29 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
542 | $872.21 | 58,401 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,600 | $378.98 | 58,401 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 4:05 pm |
N/A 2027-12-12 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,600 | $0 | 58,401 (Direct) |
View |
| 2023-12-28 Tax Withholding |
2023-12-29 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
612 | $884.88 | 58,401 (Direct) |
View |